Company profiles

Print



3S bio
Shenyang Corporate Headquarters and
Manufacturing Facilities
No.3 A1, Road 10
Shenyang Economy & Technology
Development Zone
Shenyang, China 110027
Tel: +86 24 2538 6000
Fax: +86 24 2581 1821
3S Pharmaceutical Group is a leading bio-pharmaceutical company integrating R&D, production and sales, with a focus on improving the life quality of patients with high-quality medicines to benefit human health. At present, the Group owns more than 80 national invention patents and has launched more than 30 kinds of products into the market, covering several treatment fields, among others, cancer, autoimmune, kidney disease, metabolism and dermatology. The Group owns 4 R&D centers of the National Engineering Research Center of Antibody Medicine and dual platforms for biopharmaceutical and chemical medicine. There are 25 kinds of products under R&D, 16 kinds of them are under R&D as the national first-class new drugs. The Group also owns 6 production bases complying with GMP standards. In the future, 3S Pharmaceutical Group will continue to uphold the concept of “Care for Life, Cherish Life, Create Life” to create a world's leading bio-pharmaceutical company in China.





Abbott Laboratories Trading (Shanghai) Co., Ltd.
31/F Ciro’s Plaza,288 West Nan Jing Road, Shanghai 200003, P.R. China
Tel:+86 21 23204185
At Abbott, we’re all about helping you live the best life you can through good health. We keep your heart healthy, nourish your body at every stage of life, help you feel and move better, and bring you information, medicines and breakthroughs to manage your health. Every day and around the world, we’re discovering new ways to make life better.


Ascensia Diabetes Care Shanghai Co., Ltd
Room 1307, 13/F, Borui Building, 26A Dongsanhuan Road North, Chaoyang District, Beijing 100020
Tel:+86-21-61593220
Ascensia Diabetes Care is a global company dedicated to improving the lives of people with diabetes and helping empower them to take charge of their health and happiness.
Established in 2016 through the acquisition of Bayer Diabetes Care by Panasonic Healthcare.
Holdings,Ascensia Diabetes Care is based on over 70 years of delivering innovative products and solutions that make a positive di_erence for people with diabetes.
We are determined to develop our portfolio of products, which already includes the CONTOUR™ range, so that Ascensia Diabetes Care is the recognised world leader in delivering convenient, easy-to-use blood glucose monitoring systems and testing supplies. We collaborate closely with healthcare professionals and other partners to ensure our products meet the highest standards of accuracy and compliance to help people with diabetes manage their condition optimally, regardless of type of diabetes, stage of disease or frequency of testing required.





AstraZeneca
Global Medicines Development
1 MedImmune Way, Gaithersburg,
AstraZeneca is pushing the boundaries of science to create life-changing medicines that aim to reduce the global burden and complications of diabetes. Driven to redefine outcomes for diabetes patients, our current portfolio consists of the three newest classes of non-insulin, antidiabetic treatments that support individualised treatment approaches: SGLT-2 inhibitors, GLP-1 receptor agonists and DPP-4 inhibitors. Our commitment to diabetes is exemplified by the depth and breadth of our global clinical research programme. This commitment is advancing understanding of the treatment effects of our diabetes medicines in broad patient populations, as well as exploring combination treatment approaches resulting in more patients achieving treatment success earlier in their disease progression. Our ambition is to reduce the longterm impact of diabetes. As a core strategic area for the company, we are focusing our research and development efforts in diverse populations and patients with significant co-morbidities, such as cardiovascular disease, heart failure, obesity, non-alcoholic steatohepatitis (NASH), and chronic kidney disease.





Bayer (China) Limited
Telephone: +86 10 65893000
Fax: +86 10 65893243
Bayer Health care
Tel: +86 10 5921 8282
Fax: +86 10 5921 8181
Bayer (China) Limited
No 33, Huayuan Shiqiao Road, Pudong 18-19/F, 23-26/F, Citigroup Tower, Shanghai 200120, China
Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time.
A growing and aging world population requires an adequate supply of food and improved medical care. Our research and development activities are therefore focused on improving people’s quality of life by preventing, alleviating and treating diseases. At the same time, we are making an important contribution to providing a reliable supply of high-quality food, feed and plant-based raw materials. Our understanding of the biochemical processes in living organisms helps us address these demanding challenges.
We are committed to operating sustainably and addressing our social and ethical responsibilities. We also respect the interests of all our stakeholders. Employees with a passion for innovation enjoy excellent development opportunities at Bayer.





CR Double Crane
Suite 315, No.12 Ziming Mansion, Xinzhong street, Dongcheng District, Beijing, China, 100027
CR Double-Crane Pharmaceuticals Co., Ltd is a pharmaceuticals company with 77 years of brilliant history. Sticking to the company mission of “caring for people and their health”, CR Double-Crane is always making great effort and keeping its faith. Today, the company has become a large-size listed pharmaceuticals group company with over ten subsidiaries and more than 12,000 staff. It focuses on sectors such as infusion, cardiovascular and cerebrovascular, endocrine, and pediatric medicines and has many famous products such as Compound Reserpine and Triamterene Tablets (No.O), Gliquidone Tablets , Hydroxyethyl Starch 200/0.5and Sodium Chloride Injection (Ying Yuan).





Dongbao Pharmaceutical Ltd
www.dongbao.com.cn
Founded in 1985, Tonghua Dongbao Pharmaceutical Ltd. is a conglomerate industrial group, actively engaged in the field of pharmaceutical production and is now one of the pioneering manufacturers of recombinant biopharmaceuticals, especially recombinant human insulin.Through research and innovation, we take an active part in pharmaceutical and biotech development to make valuable contribution to the world community. In Dongbao, innovative R&D programs, state-of-art technology facilities, rigorous quality control systems, effectual marketing strategies as well as satisfactory after-sales services have been integrated into a well organized business operation system. Since its establishment, Dongbao Group has demonstrated its commitment to improving people's life and adding good value to the society. Due to its achievements, Dongbao is enjoying a sound international recognition today and will endeavor to further its international collaboration.





East China
HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO.,LTD.
No.866,Moganshan Road,Hangzhou
Tel: 0571-89903388
Fax: 0571-89903366
scb05@eastchinapharm.com
www.eastchinapharm.com



HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL locates near the beautiful West Lake. The company was founded in 1992, December 31. It is a comprehensive pharmaceutical enterprise that focus on medicine, western medicine, biological technology product and its preparations. Company's existing staff of nearly 3500 people, including 900 technicians , accounting for nearly 25% of the total employees, which is a high and new tech enterprise.


Eli Lilly China
18F, tower 1 HKRI, Taikoo Hui, No. 288 Shimenyi Road, Shanghai, China
Tel: +86 21 23020000|
Eli Lilly begins with a promise…
In 1876, Colonel Eli Lilly founded the company that bears his name to make trusted medicines of the highest possible quality, based on the best science of the day.
In 2014, the people if Eli Lilly and company launched 3 new medicines to treat diabetes and cancer gained approval for 4th medicine that represent the ongoing fulfillment of the promise made more than 140 years ago by our founder.
Today, Eli Lilly and company continues to pursue the promise of innovation—guided by our core values of integrated, excellence, and respect for people—as we prepare to launch more new medicines to bring healing and hope to people around the world.
On the cover: Monica Kumado works on a packaging line for Humalog vials in Lilly’s manufacturing operations in Indianapolis. Generations of Lilly manufacturing employees have sustained Lilly’s commitment to producing quality medicines.




Gowell
Gowell Pharmaceuticals was founded in 2005, and the headquarters is located in the Chengdu High-tech Industrial Development Zone. We established a research platform on generic drug of me-too and me-better and omega-3 fatty acids. An average of 3 to 5 competitive and new products will come into market in the next five years. Omega-3 Treasure is the first epoch-making Omega-3 products with the only prescription grade fish oil. As a high-tech pharmaceutical enterprise integrated with R&D, production, marketing, we committed to make technology innovation, a high standard of quality control and professional marketing and to create value for customers, to create stage of realizing our vision for employees, to produce high quality products and services to contribute to society, and to practice corporate’s responsibility.




Johnson & Johnson Diabetes Care Companies
18F Building A, Xinyan Mansion, No. 65, Guiqing Rd., Xuhui District, Shanghai 200233, China
Tel: 800 820 1800/400 820 1800
Fax:+86 21 3337 7386
jzuo6@its.jnj.com
Johnson & Johnson Diabetes Care Companies provide total solutions to customers for In-hospital Patients Glucose Management (IPGM) in China. These solutions include not only the Blood Glucose Monitoring System (Statstrip® BGMS, cleared by FDA for use for all types of patients including the critical ill), but also the diabetes management system (DMS), the diabetic management quality evaluation model, and the online training platform (LMS) which is sponsored by JJDI. The company enjoys established reputation for diabetic care and education in China for over 20 years, and serves over  millions of patients and HCPs every year.





Medtronic plc
Floor 6-17, Building B, The New Bund World
Trade Center Phase I , No. 5, Lane 255, Dong Yu Road, Pudong, Shanghai 200126, P.R.China
Tel: +86-21 2032 5986
As a global leader in medical technology, services and solutions, Medtronic improves the lives and health of millions of people each year. We use our deep clinical, therapeutic, and economic expertise to address the complex challenges faced by healthcare systems today.
Let’s take healthcare Further, Together.


Merck Serono Co.,Ltd
25F,NUO Center office,No.A2,jiangtai Road, Chaoyang District, Beijing
With nearly 2000 employees and business presence throughout the country, Merck Healthcare is committed to serving China and markets 15 medicines in 7 major therapeutic areas. Merck Healthcare China has deep expertise in fertility and thyroid therapeutic areas, and has strong presence in CV, endocrinology and oncology. The R&D Beijing Hub, established in November 2009, is an integrated R&D facility, aimed at stimulating innovation, introducing new medicines to China even Asia paralleling market timelines in the West, and leading research and development into new treatment solutions for critical diseases in Asia.
Merck’s main therapeutic areas include fertility, oncology, cardiovascular, surgery and emergency, thyroid disease, diabetes, allergy. Product brands include Gonal-f® to treat infertility, the assistive reproduction products Ovidrel® , Luveris® , Cetrotide® , and Crinone® ; oncology product Erbitux® for the treatment of RAS WT mCRC; Concor® for high blood pressure, Stilamin® for acute gastrointestinal diseases, Euthyrox® for hypothyroidism and Thyrozol® for hyperthyroidism, Glucophage®, Glucophage XR® Glufast® for diabetes and Doxium® for diabetic ophthalmic complication, and NHD for allergies.




Microport
Shanghai MicroPort Lifesciences Co.,  Ltd
Building#24,588 Tianxiong Rd.SIMZ Bio Business Park Shanghai 201318, P.R.China
Tel: 021-38954600-3750
Shanghai MicroPort Lifesciences Co., Ltd. was founded in the Shanghai International Medical Zone on April 28, 2008. It is a wholly owned subsidiary of Shanghai MicroPort Medical (Group) Co., Ltd. and its primary focus is on the development, manufacture, monitoring and management of medical devices for the treatment of diabetes and disorders of sexual development.


MSD
For 125 years, MSD has been a global health care leader working to help the world be well. MSD is a tradename of Merck & Co., Inc., with headquarters in Kenilworth, N.J., USA. Through our prescription medicines, vaccines, biologic therapies, and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships.
About MSD in China
China is one of the most critical markets for MSD’s growth strategy. MSD China is powered by three engines: commercial operation headquartered in Shanghai, research and development in Beijing, and manufacturing in Hangzhou. We are committed to bringing quality innovative medicines, vaccines, and services to more Chinese people. For more information, visit www.msdchina.com.cn, or follow us on WeChat at msd_china




Novartis Pharmaceuticals (China)
2F, Building 1,
No. 4218 Jingke RoadZhangjiang Hi-Tech Park, PudongShanghai, 201203, China
Tel: 021-61606000
Fax: 02161603162
Novartis are inspired by patients every day.
This inspiration motivates us to revolutionize the research, development and manufacturing of quality innovative medicines that help people live longer with a better quality of life giving them more time to do the things that matter to them.
To do our best for patients we do not accept the status quo. We work to enable patient access worldwide so that patients and society can benefit as quickly as possible.
The depth and strength of our pipeline enables us to change the practice of medicine, and to bring more breakthroughswith real benefits to patients and society.   
We partner with people and organizations around the world because by working together we can make a greater difference.
We continually challenge ourselves to the highest standards of compliance, integrity and performance in all that we do to ensure a sustainable future of innovation for patients, society and Novartis.




Novo Nordisk (China) Pharmaceuticals Co., Ltd.
18F, East Tower, World Financial Center
No.1 East 3rd Ring Middle Road, Chaoyang District 100020 Beijing China
Tel: +86 10 5961 5858
Fax: +86 10 6505 6668
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia,  growth disorders and obesity Headquartered in Denmark, Novo Nordisk employs approximately 42,000 employees in 77 countries and markets its products in more than 165 countries. Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO).

Omron

Shanghai Zhizhong Medical Technology Co., Ltd is focused on the field of cardiovascular metabolic health care Internet Co, to provide overall medical instrument management system data patient management platform; solution for all levels of medical institutions, is committed to creating a large number of things based according to the metabolic cardiovascular chronic disease management cloud platform.
The Zhizhong team has more than ten years of experience in medical field operation and promotion. It has accumulated a lot in the integration of international advanced medical devices, data collection and management in hospitals, and platform operation support.
Zhizhong is currently involved in the national standardization metabolic disease management center project, China's hypertension population risk management project, the retail pharmacy chronic disease management center project and heart rate management pioneer action project. At the same time, the national blood pressure management system, family blood pressure and blood glucose intelligent management system are popularized in the whole country with its own channels.
The key project now is the national standardized metabolic disease management center, which is initiated by Chinese Medical Doctor Association and entrusted by the National Center for metabolic disease clinical medicine research, and is being built nationwide to popularize standardized management system of metabolic diseases. MMC aims to build a one-stop, standardized metabolic disease integrated management platform based on Internet of things and big data. Combined with the digital follow-up system, we will create a new mode of diagnosis and management of metabolic diseases. Zhizhong medical care is responsible for the design, development, implementation and operation of the standardized metabolic disease management center; (MMC) software system platform.





Pfizer
38/F, CITIC square, 1168 Nanjing Road(W) Shanghai 200041
Tel: (021) 60432500
Fax: (021) 52925885
Founded in 1849, Pfizer is the world’s largest research – based bio-pharmaceutical company.
We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people.
For more than 160 years, Pfizer has been working to make a difference for all who rely on us.
Our objective is to innovate to bring therapies to patients that significantly improve their lives; and Our Mission is to be the premier innovative biopharmaceutical company.


Sanofi (China)
19F Tower III, Kerry Center 1228
Middle Yan’an Road, Jing An District,
Shanghai 200040
Tel: +86 021 2226 6666


Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 110,000 people at Sanofi are dedicated to make a difference on patients’ daily life, wherever they live and enable them to enjoy a healthier life.


Servier China
6 Floor, West Building ,World Financial Center,No.1, East 3rd Ring Middle Road, Chaoyang District ,100020 Beijing China
Tel: 86 010 65610341
Fax: 86 010 65610348
Servier is the leading French independent pharmaceutical company, present in 148 countries with 21 200 employees and a turnover of 4 billion euros in 2016.
25% of Servier’s annual turnover is reinvested in Research & Development, reflecting the company’s dedication to its research mission of innovation and discovery to treat unmet medical needs.
Organized as a foundation, we guaranty our independence toward stock exchange market. As our founder Doctor Jacques Servier used to say: “a company is a group of human being, so it has no price”.
44 new chemical entities currently under development in the following therapeutic fields: cardiovascular diseases, diabetes and psychiatry, cancer research, central nervous system and metabolism, and rheumatology.





SPH Sine pharmaceutical Laboratories Co. Ltd.
No. 905, new Jinqiao Road, Pudong, Shanghai
Tel: 021-58995818 
Sine was founded in 1916 in Shanghai, and now is a wholly-owned holding company by Shanghai Pharmaceuticals Holding Co., Ltd (“SPH”), which is one of biggest pharmaceutical groups in China.
Sine is the biggest industrial subsidiary of SPH. Sine is an R&D, manufacture distribution and retail integrated company.
OUR mission is “Good drugs 、Credibility and Friendship”. Our vision is to become a respected and reputable leading pharmaceutical manufacturer and service provider.






Zeshi medical is a team focus on the promotion of innovative medical devices and technologies, provide valuable new methods for clinic. We are the Chinese partner of Israeli VIVI cooling products.
VIVI cooling products is built for patients by experts in cooling technologies to address your needs. No battery to charge, no water or ice to immerse in, no pre-cooling in refrigerator. It’s based on a combination of unique insulation material, heat absorbing chemical together with monitoring and control electronics. The proprietary technology used with VIVI cooling products combines the three to tailor a user friendly compact solution.